At 52 weeks , participants in the maintenance treatment arm did not report significantly greater abstinence rates compared with participants in the standard and extended treatment arms ( 20.3 % vs 23.8 % ; OR , 1.17 [ 95 % CI , 0.69-1 .98 ] ; P = .57 ) .